Greenwich LifeSciences, Inc. 8-K Report: Key Insights & Stock Info

$GLSI
Form 8-K
Filed on: 2024-12-19
Source
Greenwich LifeSciences, Inc. 8-K Report: Key Insights & Stock Info

Based on the provided XML section of the financial report, here are the key insights extracted:

  1. Entity Information:
  • Company Name: Greenwich LifeSciences, Inc.
  • CIK (Central Index Key): 0001799788
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-39555
  • Employer Identification Number (EIN): 20-5473709
  1. Address:
  • Location: 3992 Bluebonnet Dr, Building 14, Stafford, TX 77477
  • Contact Number: (832) 819-3232
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: December 19, 2024
  1. Stock Information:
  • Common Stock Par Value: $0.001
  • Ticker Symbol: GLSI
  • Exchange: NASDAQ
  1. Reporting Period:
  • Report Date: The report pertains to the date December 19, 2024, indicating a snapshot or event report on that specific date.
  1. Units of Measurement:
  • Currency: USD (United States Dollar)
  • Shares: The report includes measures relating to shares, though specific share amounts are not provided in this excerpt.

Summary:

The financial report provides an overview of Greenwich LifeSciences, Inc., including its basic corporate information, details about its current stock, and the specific reporting date for the 8-K filing. This information is crucial for investors and stakeholders monitoring the company's compliance and performance in the market.